As a result of this final arrangement between the parties, upon completion of the cash and share payments CMC will no longer hold a security interest in the Mill. After this acquisition, CMC will hold ...

The outstanding intersection of 7.3m at 4.2% Cu reveals a potential new lode ~250m from the main deposit; Follow-up downhole ...

Reliable exposure to long-term corporate ... investment-grade long credit analyst ranks, but it remains well-resourced. Vanguard's internal fixed-income team took over a roughly 10% sleeve of ...

“That replicates what most of the studies have ... An average of 1.3 percent of students in the district were enrolled in calculus in the three years before the eighth grade requirement took ...

“Eighth grade ... most of the studies have found,” said Scott Peters, senior research scientist at educational assessment organization NWEA.* Early algebra does appear to slightly boost enrollment in ...

NDAQ:INTS) Intensity Therapeutics Provides Business Update Highlighting Key Achievements with Lead Drug Candidate INT230-6 ...

Vir Biotechnology's recent share price rally is driven by their promising cancer program. Having shot to over a $1.5B market ...

The highest-paying open state job advertised on the South Carolina careers website pays $217,574 a year. It’s for the Circuit ...

SPR206 is an investigational, intravenously administered next-generation polymyxin that has shown antibiotic activity against MDR Gram-negative pathogens, including carbapenem-resistant ...

Sukanya Samriddhi Yojana can make up the debt component in your daughter’s education portfolio. Equities, on the other hand, ...

We're also advancing our brownfield expansion opportunities to position the business for longer-term growth ... than $1 right now, and really very limited capex, you're talking about an opportunity ...

Financial writer analysis of Arcutis Biotherapeutics, Inc. stock surge and potential growth, FDA approvals, and partnerships in 2025. Click for this ARQT update.